Albertans born in 1946 or earlier can book COVID-19 vaccine appointments starting Wednesday
Starting Wednesday at 8 a.m. MT, Albertans born in 1946 or earlier will be able to sign up for a coronavirus vaccine appointment.
Appointments can be booked online or by calling 811. There s expected to be high demand, so the province is asking people to be patient.
The appointments will be booked at 58 sites around the province, between 8:20 a.m. and 3:40 p.m., seven days a week. Those hours will be extended as more doses arrive. More than 230,000 seniors will be eligible.
Family members are allowed to book appointments for seniors but should make sure they have photo ID or an Alberta health card.
Everything you need to know about COVID-19 in Alberta on Monday, Feb 22
cbc.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbc.ca Daily Mail and Mail on Sunday newspapers.
Everything you need to know about COVID-19 in Alberta on Sunday, Feb 21
cbc.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbc.ca Daily Mail and Mail on Sunday newspapers.
New drug target valid for breast cancer as well as lymphoma
One more piece of the puzzle has fallen into place behind a new drug whose anti-cancer potential was developed at the University of Alberta and is set to begin human trials this year, thanks to newly published research.
The results provide more justification and rationale for starting the clinical trial in May. It s another exciting stepping stone to finding out if this is going to be a new cancer treatment.
John Mackey, First Author, Professor and Director of Oncology Clinical Trials, Faculty of Medicine & Dentistry, University of Alberta
The drug PCLX-001 is designed to selectively kill cancer cells by targeting enzymes involved in myristoylation, a process key to the cell signaling system that is often defective in cancer cells. The molecule was originally developed by the University of Dundee as a treatment for African sleeping sickness. U of A cell biologist Luc Berthiaume was the first to realize it could work aga
E-Mail
IMAGE: University of Alberta oncology researcher John Mackey (left) and cell biologist Luc Berthiaume are collaborators on new research showing that PCLX-001, an anti-cancer drug set to begin clinical trials this. view more
Credit: University of Alberta
One more piece of the puzzle has fallen into place behind a new drug whose anti-cancer potential was developed at the University of Alberta and is set to begin human trials this year, thanks to newly published research. The results provide more justification and rationale for starting the clinical trial in May, said first author John Mackey, professor and director of oncology clinical trials in the Faculty of Medicine & Dentistry. It s another exciting stepping stone to finding out if this is going to be a new cancer treatment.